Colitis-associated cancer and dysplasia surveillance: an opposing perspective.
Authors
Shanahan, FergusAffiliation
Alimentary Pharmabiotic Centre, Cork University Hospital, University College, Cork, National University of Ireland, Department of Medicine, Cork, Ireland., F.Shanahan@ucc.ieIssue Date
2012-02-03T15:17:05ZMeSH
Colitis, Ulcerative/*pathology*Colonoscopy/economics/utilization
Colorectal Neoplasms/epidemiology/*pathology/prevention & control
Cost-Benefit Analysis
Diagnostic Tests, Routine
Humans
Precancerous Conditions/pathology
Risk Assessment
Treatment Outcome
Metadata
Show full item recordCitation
Curr Gastroenterol Rep. 2007 Jun;9(3):175-6.Journal
Current gastroenterology reportsPubMed ID
17511913Language
engISSN
1522-8037 (Print)1522-8037 (Linking)
Collections
Related articles
- Efficiency of Colorectal Cancer Surveillance in Patients with Ulcerative Colitis: 38 Years' Experience in a Patient Cohort from a Defined Population Area.
- Authors: Rutegård M, Palmqvist R, Stenling R, Lindberg J, Rutegård J
- Issue date: 2017 Jun
- Requirements of a cancer screening program to be scientifically credible.
- Authors: Riddell RH
- Issue date: 1995 Nov
- Implications of a diagnosis of dysplasia in ulcerative colitis.
- Authors: Riddell RH
- Issue date: 1995 Nov
- Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
- Authors: Lindberg BU, Broomé U, Persson B
- Issue date: 2001 Jan
- Folate and prevention of colorectal cancer in ulcerative colitis.
- Authors: Biasco G, Di Marco MC
- Issue date: 2005 Aug